Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Centessa Pharmaceuticals (CNTA) Return on Assets: 2022-2025

Historic Return on Assets for Centessa Pharmaceuticals (CNTA) over the last 3 years, with Sep 2025 value amounting to -0.52%.

  • Centessa Pharmaceuticals' Return on Assets fell 20.00% to -0.52% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.52%, marking a year-over-year decrease of 20.00%. This contributed to the annual value of -0.50% for FY2024, which is 13.00% down from last year.
  • Per Centessa Pharmaceuticals' latest filing, its Return on Assets stood at -0.52% for Q3 2025, which was down 14.26% from -0.45% recorded in Q2 2025.
  • Over the past 5 years, Centessa Pharmaceuticals' Return on Assets peaked at -0.32% during Q3 2024, and registered a low of -0.52% during Q3 2025.
  • Its 3-year average for Return on Assets is -0.43%, with a median of -0.41% in 2023.
  • Its Return on Assets has fluctuated over the past 5 years, first grew by 10bps in 2024, then decreased by 20bps in 2025.
  • Quarterly analysis of 4 years shows Centessa Pharmaceuticals' Return on Assets stood at -0.47% in 2022, then increased by 6bps to -0.41% in 2023, then climbed by 1bps to -0.40% in 2024, then declined by 20bps to -0.52% in 2025.
  • Its Return on Assets was -0.52% in Q3 2025, compared to -0.45% in Q2 2025 and -0.41% in Q1 2025.